Simplifying surgical criteria for early-stage cervical cancer: prognostic equivalence of total vs. radical hysterectomy in a retrospective SEER cohort analysis
Open Access
- 13 June 2025
- journal article
- other
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (9) , 6211-6220
Abstract
Background: The prognostic equivalence of total hysterectomy (TH) versus radical hysterectomy (RH) in early-stage cervical cancer (IA2-IB1) with tumor size ≤2 cm remains controversial, particularly regarding the necessity of lymphovascular space invasion (LVSI) assessment. This study evaluates survival outcomes under simplified criteria omitting LVSI and depth of invasion evaluation. Materials and methods: This retrospective cohort study analyzed 3002 FIGO IA2-IB1 cervical cancer patients (tumors ≤2 cm) from the SEER database (2004–2019). Inclusion criteria are histologically confirmed adenocarcinoma, adenosquamous carcinoma, or squamous cell carcinoma; TH/RH with lymphadenectomy/sentinel node biopsy. Outcomes included overall survival (OS) and disease-specific survival (DSS), analyzed via Kaplan–Meier, Cox regression, and propensity score matching (PSM). Results: Median follow-up was 73 months. No significant differences were observed in OS (92.3% vs. 92.3%, P = 0.74) and DSS (96.4% vs. 96.6%, P = 0.89) outcomes between RH and TH cohorts, consistent across FIGO stages and adjuvant therapy-without patients. Multivariable analysis confirmed age >49 years (HR = 2.50, 95% CI = 1.91–3.28, P < 0.01), marital status of separated/divorced/widowed (HR = 1.66, 95% CI = 1.20–2.28, P < 0.01), and tumor size 11–20 mm (HR = 1.61, 95% CI = 1.18–2.19, P < 0.01) as independent risk factors in OS. While surgical approach still showed no prognostic significance both in OS (HR = 1.04, 95% CI = 0.79–1.37, P = 0.77) and DSS (HR = 1.01, 95% CI = 0.67–1.53, P = 0.96). Post-PSM analysis ( n = 2,715) confirmed survival equivalence ( P > 0.05). However, in IB1 adenosquamous/adenocarcinoma patients aged >49 years with tumors 11–20 mm, RH achieved superior DSS ( P = 0.01), though OS differences were nonsignificant ( P = 0.085). Squamous carcinoma outcomes remained equivalent regardless of surgery ( P = 0.43). Conclusion: TH achieves survival outcomes comparable to RH in most early-stage cervical cancer patients with tumors ≤2 cm, supporting its application in low-risk populations. However, RH remains preferred for stage IB1 patients with adenocarcinoma or adenosquamous carcinoma aged >49 years and tumors measuring 11–20 mm. Simplified criteria omitting LVSI and stromal depth assessment may enhance accessibility in resource-limited settings without compromising safety.Keywords
This publication has 19 references indexed in Scilit:
- Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysisThe Lancet Global Health, 2020
- Revised FIGO staging for carcinoma of the cervix uteriInternational Journal of Gynecology & Obstetrics, 2019
- Complications of lymphadenectomy for gynecologic cancerEuropean Journal of Surgical Oncology, 2013
- Quality of Life and Sexual Functioning in Cervical Cancer SurvivorsJournal of Clinical Oncology, 2005
- Cervical cancerThe Lancet, 2003
- Anorectal Dysfunction After Surgical Treatment for Cervical CancerJournal of the American College of Surgeons, 2002
- The Prognostic Factors for Patients with Early Cervical Cancer Treated by Radical Hysterectomy and Postoperative RadiotherapyGynecologic Oncology, 1999
- Vaginal Changes and Sexuality in Women with a History of Cervical CancerNew England Journal of Medicine, 1999
- Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group studyGynecologic Oncology, 1990
- The effect of Wertheim hysterectomy upon bladder and urethral functionAmerican Journal of Obstetrics and Gynecology, 1981